Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23792 | 23478246 | Minerva Gastroenterol Dietol | Liver steatosis in celiac disease: the open door. | 2013 | Details |
| A23793 | 23478245 | Minerva Gastroenterol Dietol | Management of non-alcoholic fatty liver disease. | 2013 | Details |
| A23794 | 23477746 | Atherosclerosis | The ERLIN1-CHUK-CWF19L1 gene cluster influences liver fat deposition and hepatic inflammation in the NHLBI Family Heart Study. | 2013 | Details |
| A23795 | 23477499 | Antioxid Redox Signal | Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. | 2013 | Details |
| A23796 | 23476686 | Evid Based Complement Alternat Med | Managing the combination of nonalcoholic Fatty liver disease and metabolic syndrome with chinese herbal extracts in high-fat-diet fed rats. | 2013 | Details |
| A23797 | 23475581 | Curr Diab Rep | Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. | 2013 | Details |
| A23799 | 23472083 | PLoS One | Hepatic methionine homeostasis is conserved in C57BL/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism. | 2013 | Details |
| A23800 | 23467489 | Lab Anim | Gender and strain-specific differences in the development of steatosis in rats. | 2013 | Details |
| A23801 | 23466642 | Horm Res Paediatr | Nonalcoholic fatty liver disease in prepubertal children born small for gestational age: influence of rapid weight catch-up growth. | 2013 | Details |
| A23802 | 23465592 | J Nutr Biochem | S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. | 2013 | Details |
| A23804 | 23461136 | Adv Clin Chem | Toll-like receptors in liver disease. | 2013 | Details |
| A23805 | 23460643 | J Biol Chem | Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. | 2013 | Details |
| A23806 | 23458891 | Nat Rev Gastroenterol Hepatol | NAFLD in Asia--as common and important as in the West. | 2013 | Details |
| A23807 | 23458397 | Photodermatol Photoimmunol Photomed | Is non-alcoholic steatohepatitis a predisposing factor to porphyria cutanea tarda? | 2013 | Details |
| A23808 | 23458257 | Clin Sci (Lond) | Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease. | 2013 | Details |
| A23809 | 23458042 | J Coll Physicians Surg Pak | Etiology, clinical spectrum and outcome of metabolic liver diseases in children. | 2013 | Details |
| A23810 | 23454028 | Clin Gastroenterol Hepatol | Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. | 2013 | Details |
| A23811 | 23453736 | Syst Appl Microbiol | Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula. | 2013 | Details |
| A23812 | 23453039 | Metabolism | Involvement of regucalcin in lipid metabolism and diabetes. | 2013 | Details |
| A23813 | 23452341 | Br J Clin Pharmacol | The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. | 2014 | Details |
| A23814 | 23452186 | Clin Microbiol Infect | Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? | 2013 | Details |
| A23815 | 23452163 | Clin Microbiol Infect | Gut microbiota and non-alcoholic fatty liver disease: new insights. | 2013 | Details |
| A23816 | 23451184 | PLoS One | Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. | 2013 | Details |
| A23817 | 23451176 | PLoS One | Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. | 2013 | Details |
| A23818 | 23449226 | AIDS Rev | The changing epidemiology of liver disease in HIV patients. | 2013 | Details |
| A23819 | 23448101 | DNA Cell Biol | Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. | 2013 | Details |
| A23820 | 23447513 | Pediatr Obes | Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children. | 2013 | Details |
| A23821 | 23447451 | Hepatology | Desmosterol in human nonalcoholic steatohepatitis. | 2013 | Details |
| A23823 | 23444782 | Pharmazie | Effects of a new sustained-release microsphere formulation of exenatide, DA-3091, on obese and non-alcoholic fatty liver disease mice. | 2013 | Details |
| A23824 | 26201622 | Hepatol Int | Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. | 2012 | Details |
| A23825 | 26064833 | J Lifestyle Med | Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs. | 2013 | Details |
| A23826 | 25755474 | J Clin Exp Hepatol | Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report. | 2013 | Details |
| A23827 | 25755466 | J Clin Exp Hepatol | Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. | 2012 | Details |
| A23828 | 23442837 | J Clin Gastroenterol | Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease. | 2013 | Details |
| A23829 | 23442833 | J Clin Gastroenterol | Immune therapy for nonalcoholic steatohepatitis: are we there yet? | 2013 | Details |
| A23830 | 23441892 | Aliment Pharmacol Ther | Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease. | 2013 | Details |
| A23831 | 23441159 | PLoS One | PKCδ as a regulator for TGFβ1-induced α-SMA production in a murine nonalcoholic steatohepatitis model. | 2013 | Details |
| A23833 | 23439872 | FASEB J | Strain-dependent dysregulation of one-carbon metabolism in male mice is associated with choline- and folate-deficient diet-induced liver injury. | 2013 | Details |
| A23834 | 23439771 | Diabetes Metab J | Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. | 2013 | Details |
| A23835 | 23439508 | Acta Med Okayama | A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts. | 2013 | Details |
| A23836 | 23439261 | J Hepatol | The liver diseases of lipodystrophy: the long-term effect of leptin treatment. | 2013 | Details |
| A23837 | 23439214 | Angiology | Association between nonalcoholic fatty liver disease and coronary artery disease complexity in patients with acute coronary syndrome: a pilot study. | 2013 | Details |
| A23838 | 23435355 | Biochem Pharmacol | Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. | 2013 | Details |
| A23839 | 23433827 | Med Hypotheses | Hedgehog signalling pathway in adult liver: a major new player in hepatocyte metabolism and zonation? | 2013 | Details |
| A23840 | 23433458 | Adv Pharmacol | Eicosanoids in metabolic syndrome. | 2013 | Details |
| A23841 | 23432982 | Arab J Gastroenterol | Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. | 2012 | Details |
| A23842 | 23432843 | Liver Int | GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK. | 2013 | Details |
| A23843 | 23432669 | Curr Pharm Des | Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. | 2013 | Details |
| A23844 | 23432668 | Curr Pharm Des | Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. | 2013 | Details |
| A23845 | 23431468 | ISRN Endocrinol | Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |
| A23847 | 23431294 | Int J Endocrinol | Hepatic steatosis and thyroid function tests in overweight and obese children. | 2013 | Details |
| A23848 | 23431284 | PPAR Res | Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility? | 2013 | Details |
| A23849 | 23430399 | Med Mol Morphol | A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. | 2013 | Details |
| A23850 | 23430039 | World J Gastroenterol | What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? | 2013 | Details |
| A23851 | 23426824 | J Pediatr Endocrinol Metab | Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population. | 2012 | Details |
| A23852 | 23426822 | J Pediatr Endocrinol Metab | Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2012 | Details |
| A23853 | 23426790 | Int J Mol Med | Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway. | 2013 | Details |
| A23854 | 23426707 | Exp Clin Endocrinol Diabetes | Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease. | 2013 | Details |
| A23855 | 23426271 | Eur J Gastroenterol Hepatol | Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease. | 2013 | Details |
| A23856 | 23425054 | J Gastroenterol Hepatol | Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis. | 2013 | Details |
| A23857 | 23425053 | J Gastroenterol Hepatol | Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance? | 2013 | Details |
| A23858 | 23424927 | Rev Prat | [Treatment of nonalcoholic steatohepatitis]. | 2012 | Details |
| A23859 | 23424926 | Rev Prat | [Management of non alcoholic fatty liver diseases in adults]. | 2012 | Details |
| A23861 | 23424924 | Rev Prat | [Epidemiology and natural history of nonalcoholic fatty liver disease]. | 2012 | Details |
| A23862 | 23423795 | J Magn Reson Imaging | Magnetic resonance elastography of liver: technique, analysis, and clinical applications. | 2013 | Details |
| A23863 | 23420151 | Clinics (Sao Paulo) | Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. | 2013 | Details |
| A23864 | 23419824 | J Hepatol | The burden of liver disease in Europe: a review of available epidemiological data. | 2013 | Details |
| A23865 | 23419734 | Nutr Metab Cardiovasc Dis | Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers. | 2013 | Details |
| A23866 | 23419204 | Atherosclerosis | Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. | 2013 | Details |
| A23867 | 23418085 | Obesity (Silver Spring) | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. | 2013 | Details |
| A23868 | 23418072 | Obesity (Silver Spring) | A metabolically healthy obese phenotype in hispanic participants in the IRAS family study. | 2013 | Details |
| A23869 | 23417738 | J Lipid Res | Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. | 2013 | Details |
| A23870 | 23416328 | Clin Gastroenterol Hepatol | Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey. | 2013 | Details |
| A23871 | 23416144 | Drug Discov Today | Cysteamine: an old drug with new potential. | 2013 | Details |
| A23872 | 23415870 | Int Immunopharmacol | Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats. | 2013 | Details |
| A23873 | 23415456 | Nutr Metab Cardiovasc Dis | Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. | 2013 | Details |
| A23874 | 23411507 | Endocr J | High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. | 2013 | Details |
| A23875 | 23410526 | Biochim Biophys Acta | Prevention and reversal of hepatic steatosis with a high-protein diet in mice. | 2013 | Details |
| A23876 | 23406781 | Ann Nutr Metab | Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. | 2013 | Details |
| A23877 | 23406705 | Pediatr Exerc Sci | Cardiorespiratory fitness, but not central obesity or C-reactive protein, is related to liver function in obese children. | 2013 | Details |
| A23880 | 23406154 | Lipids Health Dis | Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice. | 2013 | Details |
| A23881 | 23405890 | Clin Endocrinol (Oxf) | Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders. | 2013 | Details |
| A23883 | 23405244 | PLoS One | Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example. | 2013 | Details |
| A23884 | 23404955 | Obesity (Silver Spring) | Alterations in adipocytokines and cGMP homeostasis in morbid obesity patients reverse after bariatric surgery. | 2013 | Details |
| A23885 | 23403440 | J Pediatr Gastroenterol Nutr | Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. | 2013 | Details |
| A23886 | 23402636 | J Med Food | Health benefits of blue-green algae: prevention of cardiovascular disease and nonalcoholic fatty liver disease. | 2013 | Details |
| A23887 | 23402081 | Acta Gastroenterol Belg | Pleiotropic functions of bile acids mediated by the farnesoid X receptor. | 2012 | Details |
| A23888 | 23401753 | J Obes | Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice. | 2013 | Details |
| A23889 | 23401313 | Hepatology | Intestinal microbiota in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23890 | 23400921 | Subcell Biochem | Relevance of CYP2E1 to non-alcoholic fatty liver disease. | 2013 | Details |
| A23891 | 23399520 | J Epidemiol | Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China. | 2013 | Details |
| A23892 | 23398788 | Arch Med Res | Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study. | 2013 | Details |
| A23893 | 23398678 | Colorectal Dis | Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy. | 2013 | Details |
| A23894 | 23398201 | Biol Cell | PNPLA3/adiponutrin functions in lipid droplet formation. | 2013 | Details |
| A23895 | 23360884 | Br J Nutr | Gut microbiota and metabolic disorders: How prebiotic can work? | 2013 | Details |
| A23896 | 23397556 | Semin Thromb Hemost | Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. | 2013 | Details |
| A23897 | 23397532 | Semin Liver Dis | A critical appraisal of advances in pediatric nonalcoholic Fatty liver disease. | 2013 | Details |
| A23898 | 23397118 | J Gastroenterol | Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. | 2013 | Details |
| A23899 | 23396737 | Ann Hepatol | Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. | 2013 | Details |